Jefferies Sees Another 26% Upside to Green Plains Renewable (GPRE); PT Raised
Get Alerts GPRE Hot Sheet
Price: $21.16 -2.71%
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Rating Summary:
12 Buy, 3 Hold, 0 Sell
Rating Trend: Up
Today's Overall Ratings:
Up: 11 | Down: 12 | New: 13
Join SI Premium – FREE
Jefferies analyst Laurence Alexander reiterated a Buy rating and boosted its price target on Green Plains Renewable Energy (NASDAQ: GPRE) from $28 to $40.
Alexander comments, "Green Plains has rallied sharply on the combination of strong ethanol margins and optimism of a favorable settlement of the RFS debate. We are raising our price target $12 to $40, 26% above the current share price. The rally to mid-cycle value is done. The next step is more speculative, but still likely"
The firm boosted FY 2014 EPS from $2.05 to $2.35 and FY 2015 EPS from $2.15 to $2.30.
For an analyst ratings summary and ratings history on Green Plains Renewable Energy click here. For more ratings news on Green Plains Renewable Energy click here.
Shares of Green Plains Renewable Energy closed at $31.81 yesterday.
Alexander comments, "Green Plains has rallied sharply on the combination of strong ethanol margins and optimism of a favorable settlement of the RFS debate. We are raising our price target $12 to $40, 26% above the current share price. The rally to mid-cycle value is done. The next step is more speculative, but still likely"
The firm boosted FY 2014 EPS from $2.05 to $2.35 and FY 2015 EPS from $2.15 to $2.30.
For an analyst ratings summary and ratings history on Green Plains Renewable Energy click here. For more ratings news on Green Plains Renewable Energy click here.
Shares of Green Plains Renewable Energy closed at $31.81 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Keurig Dr Pepper (KDP) PT Raised to $39 at Jefferies
- META to capture largest share of users, SNAP to benefit from ad budget shifts - Canaccord Genuity weighs in on TikTok ban
- Sage Therapeutics (SAGE) PT Lowered to $18 at Truist Securities
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst PT ChangeRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!